Published in Pediatr Infect Dis J on November 01, 1996
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax (2001) 4.68
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Antimicrob Agents Chemother (1999) 2.63
What Is the Clinical Impact of Macrolide Resistance? Curr Infect Dis Rep (2004) 1.00
Ribosomal Resistance: Emerging Problems and Potential Solutions. Curr Infect Dis Rep (1999) 0.85
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective. Clin Microbiol Rev (2016) 0.82
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. Antimicrob Agents Chemother (2003) 0.79
Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact? Can J Infect Dis (2002) 0.75
Congenital rubella. Clinicopathologic, virologic, and immunologic studies. Am J Dis Child (1965) 2.82
Pertussis. Medicine (Baltimore) (1975) 2.41
Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther (2007) 2.17
Herpesvirus infections of the human central nervous system. N Engl J Med (1967) 2.09
Global cerebral ischemia: effects of pentastarch after reperfusion. Anesth Analg (1994) 2.04
Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00
Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet (1992) 1.94
Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med (2000) 1.80
Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet (1999) 1.79
Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet (1999) 1.67
Acute hepatic failure associated with the use of sodium valproate. N Engl J Med (1979) 1.55
Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48
Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46
Application of pharmacokinetics in the diagnosis of chemical abuse in Münchausen syndrome by proxy. Clin Pediatr (Phila) (1988) 1.38
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics (1999) 1.36
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Evaluation of orally administered antibiotics for treatment of upper respiratory infections in Thai children. J Pediatr (1971) 1.32
Acetaminophen overdose with therapeutic intent. J Pediatr (1998) 1.29
Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis. Arch Neurol (1968) 1.27
Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J (1992) 1.26
Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother (1997) 1.25
Neonatal infections caused by group B streptococci. Am J Obstet Gynecol (1973) 1.25
Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther (1999) 1.22
Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother (1985) 1.20
Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J Pediatr (1982) 1.19
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther (2007) 1.18
Treatment of neonatal hypertension with enalaprilat. J Pediatr (1990) 1.17
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Clin Pharmacol Ther (2000) 1.12
Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther Drug Monit (1982) 1.12
Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am (1997) 1.12
Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr (1991) 1.10
Invasive Haemophilus influenzae type f disease. Pediatr Infect Dis J (1995) 1.07
Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol (1992) 1.06
Treatment of pain with gabapentin in a neonate. Pediatrics (2001) 1.05
Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells. Transplantation (1991) 1.02
The neurotoxicity of cyclotrimethylenetrinitramine (RDX) in a child: a clinical and pharmacokinetic evaluation. J Toxicol Clin Toxicol (1986) 1.01
Cocaine: clinical pharmacology and toxicology. J Pediatr (1989) 1.01
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab Dispos (1999) 0.99
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther (1998) 0.99
Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther (2001) 0.97
Staphylococcal CNS infections treated with vancomycin and rifampin. Arch Neurol (1984) 0.97
Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol (2002) 0.96
A mixed epidemic associated with echovirus types 6 and 11: virologic, clinical and epidemiologic studies. Am J Epidemiol (1981) 0.96
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol (2001) 0.96
Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. Pacing Clin Electrophysiol (1989) 0.95
Internal cardioverter defibrillator: component failure. Pacing Clin Electrophysiol (1990) 0.95
Single-dose pharmacokinetics of imipenem in children. J Pediatr (1984) 0.95
Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther (1999) 0.93
Nifedipine poisoning in a child. Pediatrics (1990) 0.92
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol (2001) 0.92
Pyogenic arthritis associated with adjacent osteomyelitis: identification of the sequela-prone child. Pediatr Infect Dis J (1992) 0.92
Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) (2001) 0.91
The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol (1998) 0.91
Herpes simplex encephalitis: brain biopsy and treatment with 5-iodo-2'-deoxyuridine. J Pediatr (1968) 0.91
Psychiatric syndromes in patients with the automatic internal cardioverter defibrillator: anxiety, psychological dependence, abuse, and withdrawal. Am Heart J (1989) 0.91
Normal cerebrospinal fluid values in children: another look. Pediatrics (1985) 0.91
Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving target. Clin Pharmacol Ther (2012) 0.90
Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther (2010) 0.89
Gentamicin pharmacokinetics in neonates with patent ductus arteriosus. Crit Care Med (1997) 0.89
Protein-calorie malnutrition impairs the anti-viral function of macrophages. Proc Soc Exp Biol Med (1978) 0.89
Epistaxis and bullae in cynomolgus macaques (Macaca fascicularis). Lab Anim Sci (1983) 0.88
Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm (1998) 0.88
Replication of dengue virus type 2 in Aedes albopictus cell culture. J Virol (1973) 0.88
Respiratory tract excretion of cytomegalovirus in Thai children. J Pediatr (1970) 0.87
Age-related differences in digoxin toxicity and its treatment. Drug Saf (1992) 0.87
Encephalopathy and fatty degeneration of the viscera in Thai children. Am J Dis Child (1970) 0.87
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping. Pharmacogenetics (1998) 0.87
Virus-associated hemophagocytic syndrome: relationship to herpes group viruses. Pediatr Infect Dis (1986) 0.87
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrob Agents Chemother (1986) 0.87
The epidemiology of hepatitis B antigen in a high prevalence area. Am J Epidemiol (1973) 0.86
Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr (1992) 0.86
Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis. J Pediatr (1985) 0.86
Pituitary abscess: an unusual presentation of "aseptic meningitis". J Pediatr Endocrinol Metab (1995) 0.86
Multisystem group A beta-hemolytic streptococcal disease in children. Rev Infect Dis (1992) 0.86
Pertussis in the young infant. Semin Respir Infect (1995) 0.85
The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated. J Nutr (2001) 0.85
Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther (2001) 0.84
Hong Kong influenza in U.S. military airmen in Thailand. Am J Trop Med Hyg (1970) 0.84
Left pleural effusion: masking subphrenic abscess--caused by Salmonella enteritidis serotype Heidelberg. Clin Pediatr (Phila) (1989) 0.84
Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol (1996) 0.84
Effect of age and renal function on cefonicid pharmacokinetics. Antimicrob Agents Chemother (1989) 0.83
Encephalitis associated with Trypanosoma cruzi in a Celebes black macaque. Lab Anim Sci (1986) 0.83
Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrob Agents Chemother (1998) 0.83
Antimicrobial therapy for pediatric patients. Pediatr Clin North Am (1989) 0.83
Clinical pharmacology as a foundation for translational science. Clin Pharmacol Ther (2011) 0.83
Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther (1998) 0.82
Absence of a pharmacokinetic interaction between chloramphenicol and acetaminophen in children. J Pediatr (1985) 0.82
Serum sickness-like reactions associated with cefprozil therapy. J Pediatr (1994) 0.82
Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children. Antimicrob Agents Chemother (1995) 0.82
Clinical effect of allopurinol on preserved kidneys: a randomized double-blind study. Ann Surg (1977) 0.82
Resistance of Pasteurella multocida to rabbit neutrophil phagocytosis and killing. Am J Vet Res (1981) 0.82
Role of macrophages in Wesselsbron and Germiston virus infections of mice. J Infect Dis (1975) 0.81
Perirectal abscess in children. Am J Dis Child (1974) 0.81
Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol (1998) 0.81